TGFB1 and cancer: While the immune evasion mechanisms of specific CAF subtypes remain largely unknown [30,31], Chakravarthy et al. recently identified a subset of ECM genes, specifically dysregulated in cancer, that are modulated in CAFs through a transcriptional program associated with TGF-β signaling in the TME and its enrichment in hot tumors, indicating a function in immune escape.